08:00 , Dec 16, 2013 |  BC Week In Review  |  Company News

Ariana, Bruker, University Hospitals of Strasbourg, University of Strasbourg diagnostic news

Ariana launched its ExtempoNMR project, which is partnered with Bruker's Bruker Biospin subsidiary, the university and university hospitals, to develop a tool for in vitro cancerous tissue diagnosis during surgical procedures. The tool will be...
08:00 , Mar 3, 2008 |  BC Week In Review  |  Company News

Bruker, Bruker BioSpin Corp. deal

Bruker Corp. (formerly Bruker BioSciences Corp.) completed its previously announced acquisition of Bruker BioSpin for $1 billion in cash and stock (see BioCentury, Dec. 10, 2007). Bruker paid $388 million in cash and issued about...
08:00 , Dec 10, 2007 |  BC Week In Review  |  Company News

Bruker BioSciences Corp., Bruker BioSpin Corp. deal

BRKR will acquire Bruker BioSpin for $922.2 million consisting of $388 million in cash and 57.5 million BRKR shares worth $534.2 million based on BRKR's close of $9.29 on Nov. 30, the last trading day...
07:00 , Oct 22, 2001 |  BioCentury  |  Finance

Ebb & Flow

Trading in Genzyme (GENZ) provided for some read as to how the market weighs current EPS vs. potential future profits. GENZ's solid third quarter results and a boost in revenue projections for its Renagel phosphate...
07:00 , Oct 17, 2001 |  BC Extra  |  Financial News

GeneFormatics raises $22 million

GeneFormatics (San Diego, Calif.), which is using in silico technologies to analyze human protein sequences and pathogen proteomes, raised $22 million in a private financing. Investors included Bruker AXS; Bruker BioSpin; Bruker Daltonics (BDAL); TaKaRa...
07:00 , Oct 8, 2001 |  BC Week In Review  |  Company News

GeneFormatics, Bruker AXS, Bruker BioSpin Corp., Bruker Daltonics deal

GeneFormatics, BDAL, Bruker BioSpin and Bruker AXS will develop technologies for analyzing 3-D protein structures. Bruker BioSpin will be responsible for developing high throughput NMR spectroscopy, Bruker AXS for X-ray SCD and BDAL for MALDI-TOF...
07:00 , Oct 3, 2001 |  BC Extra  |  Company News

GeneFormatics, Bruker companies in proteomics deal

GeneFormatics (San Diego, Calif.), Bruker Daltonics (BDAL), Bruker BioSpin and Bruker AXS will collaborate to develop technologies for analyzing 3-D protein structures. Bruker BioSpin will be responsible for developing high throughput NMR spectroscopy, Bruker AXS...
07:00 , Aug 6, 2001 |  BioCentury  |  Finance

Ebb & Flow

Integrative Proteomics raised $25 million last week through a group of investors that looked more like a who's-who of life science instrumentation suppliers than an investor syndicate. The group included Vertex's newly acquired Aurora Biosciences...
08:00 , Mar 19, 2001 |  BC Week In Review  |  Company News

Integrative Proteomics, Bruker BioSpin Group deal

Bruker BioSpin companies Bruker Daltonics Inc. (BDAL; Billerica, Mass.), Bruker AXS Inc. (Madison, Wis.), and Bruker Instruments Inc., (Billerica, Mass.) will make equity investments in Integrative Proteomics. In addition, Integrative Proteomics will obtain X-ray, NMR...